Stephen L Lessnick

10PUBLICATIONS
45CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jun 15, 2026
The DBD-α4 helix of EWSR1::FLI1 is required for GGAA microsatellite binding that underlies genome regulation in Ewing sarcoma.

|Feb 14, 2024
DBD-α4 helix of EWSR1::FLI1 is required for GGAA microsatellite binding that underlies genome regulation in Ewing sarcoma.

Ariunaa Bayanjargal, Cenny Taslim, Iftekhar A Showpnil

|Jan 20, 2023
Randomized Phase III Trial of Ganitumab With Interval-Compressed Chemotherapy for Patients With Newly Diagnosed Metastatic Ewing Sarcoma: A Report From the Children's Oncology Group.

Steven G DuBois, Mark D Krailo, Julia Glade-Bender

|Jan 19, 2023
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS-FLI to promote Ewing sarcoma.

Diana Y Lu, Jana M Ellegast, Kenneth N Ross

|Oct 11, 2022
Adverse prognostic impact of the loss of STAG2 protein expression in patients with newly diagnosed localised Ewing sarcoma: A report from the Children's Oncology Group.

David S Shulman, Sonja Chen, David Hall

|Sep 17, 2022
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma.

David S Shulman, Sarah B Whittle, Didier Surdez

Pageof 2

Frequent Collaborators

5 joint publications

Emily Rose Theisen

4 joint publications

Cenny Taslim

2 joint publications

Ariunaa Bayanjargal

2 joint publications

Megann A Boone